|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,550.00 JPY | -0.28% |
|
-2.47% | -8.03% |
| 02-06 | BML, Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026 | CI |
| 02-06 | BML, Inc. Reports Earnings Results for the Nine Months Ended December 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 825M | - | - | |||
| 33.14B | - | ||||
| 20.98B | |||||
| 6.95B | |||||
| 4.23B | - | - | |||
| 2.9B |
- Stock Market
- Stocks
- 4694 Stock
- Charts BML, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
